BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3
62 results:

  • 1. Clinical significance of EVI-1 gene expression and aberrations in patient with de-novo acute myeloid and acute lymphoid leukemia.
    Nabil R; Abdellateif MS; Gamal H; Hassan NM; Badawy RH; Ghareeb M; El Ashry MS
    Leuk Res; 2023 Mar; 126():107019. PubMed ID: 36657369
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Case report: A rare case of coexisting Waldenstrom Macroglobulinemia and B-cell acute lymphoblastic leukemia with KMT2D and mecom mutations.
    Wang L; Tang J; Feng J; Huang Y; Cheng Y; Xu H; Miao Y
    Front Immunol; 2022; 13():1001482. PubMed ID: 36325357
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical features and prognostic implications of ecotropic viral integration site 1 (
    Jia M; Hu BF; Zhang JY; Xu LY; Tang YM
    Pediatr Hematol Oncol; 2023 May; 40(4):371-381. PubMed ID: 36111831
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Low evi1 expression at diagnosis predicted poor outcomes in pediatric Ph-negative B cell precursor acute lymphoblastic leukemia patients.
    Yang L; Dao FT; Lu AD; Chen WM; Li LD; Long LY; Liu YR; Liu KY; Zhang LP; Qin YZ
    Pediatr Hematol Oncol; 2022 Mar; 39(2):97-107. PubMed ID: 34156313
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. NKL Homeobox Gene VENTX Is Part of a Regulatory Network in Human Conventional Dendritic Cells.
    Nagel S; Pommerenke C; Meyer C; Drexler HG
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072771
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Rare and novel RUNX1 fusions in myeloid neoplasms: A single-institute experience.
    Aypar U; Yao J; Londono DM; Khoobyar R; Scalise A; Arcila ME; Roshal M; Xiao W; Zhang Y
    Genes Chromosomes Cancer; 2021 Feb; 60(2):100-107. PubMed ID: 33078873
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study.
    Torres HA; Lok AS; Suarez-Almazor ME; Warneke CL; Kaseb A; Miller E; Sturgis EM; Foreman JT; Angelidakis G; Ahmed S; Ferrajoli A; Samaniego F; Hawk ET; Hwang JP
    Support Care Cancer; 2021 Jan; 29(1):97-105. PubMed ID: 32314052
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Lenalidomide Plus Hypomethylating Agent as a Treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities-AML With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, mecom.
    Merz LE; Perissinotti AJ; Marini BL; Burke PW; Crouch A; Erba HP; Bixby D
    Clin Lymphoma Myeloma Leuk; 2020 Jan; 20(1):24-30. PubMed ID: 31711889
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. evi1 triggers metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase.
    Saito Y; Sawa D; Kinoshita M; Yamada A; Kamimura S; Suekane A; Ogoh H; Matsuo H; Adachi S; Taga T; Tomizawa D; Osato M; Soga T; Morishita K; Moritake H
    Haematologica; 2020 Aug; 105(8):2118-2129. PubMed ID: 31649131
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.
    Shiba N; Yoshida K; Hara Y; Yamato G; Shiraishi Y; Matsuo H; Okuno Y; Chiba K; Tanaka H; Kaburagi T; Takeuchi M; Ohki K; Sanada M; Okubo J; Tomizawa D; Taki T; Shimada A; Sotomatsu M; Horibe K; Taga T; Adachi S; Tawa A; Miyano S; Ogawa S; Hayashi Y
    Blood Adv; 2019 Oct; 3(20):3157-3169. PubMed ID: 31648321
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT.
    Pavlů J; Labopin M; Niittyvuopio R; Socié G; Yakoub-Agha I; Wu D; Remenyi P; Passweg J; Beelen DW; Aljurf M; Kröger N; Labussière-Wallet H; Perić Z; Giebel S; Nagler A; Mohty M
    J Hematol Oncol; 2019 Oct; 12(1):108. PubMed ID: 31647022
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas.
    Manconi L; Coviello E; Canale F; Giannoni L; Minetto P; Guolo F; Clavio M; Marcolin R; Cea M; Cagnetta A; Gobbi M; Miglino M; Ballerini F; Lemoli RM
    Leuk Lymphoma; 2020 Jan; 61(1):84-90. PubMed ID: 31480933
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma.
    Aladily TN; Mansour A; Alsughayer A; Sughayer M; Medeiros LJ
    Ann Diagn Pathol; 2019 Jun; 40():72-76. PubMed ID: 31075666
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/lymphoma Study Group AML-05 study.
    Miyamura T; Moritake H; Nakayama H; Tanaka S; Tomizawa D; Shiba N; Saito AM; Tawa A; Shimada A; Iwamoto S; Hayashi Y; Koike T; Horibe K; Manabe A; Mizutani S; Taga T; Adachi S
    Br J Haematol; 2019 Apr; 185(2):284-288. PubMed ID: 30784060
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. B-cell peripheral neurolymphomatosis: MRI and
    DeVries AH; Howe BM; Spinner RJ; Broski SM
    Skeletal Radiol; 2019 Jul; 48(7):1043-1050. PubMed ID: 30666391
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Multiple myeloma secondary to acute lymphoblastic leukemia: A case report.
    Hu T; Shen J; Liu W; Zheng Z
    Medicine (Baltimore); 2019 Jan; 98(1):e14018. PubMed ID: 30608452
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. evi1 expression predicts outcome in higher-risk myelodysplastic syndrome patients.
    Liu L; Wang J; Jiang Y; Xie H; Tang X; Li Q; Wang H; Zou P; Miao Z; Lv Y; Wang H; Cao Z; Zhao Z
    Leuk Lymphoma; 2018 Dec; 59(12):2929-2940. PubMed ID: 29846125
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci.
    Adams T; Fuchs D; Shadoan PK; Johnstone L; Lau BM; McGhan L; Anwer F; Al-Kateb H
    Cancer Genet; 2018 Apr; 222-223():25-31. PubMed ID: 29666005
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Ecotropic viral integration site I regulates alpha1, 6-fucosyl transferase expression and blocks erythropoiesis in chronic myeloid leukemia.
    Kuila N; Nayak KB; Halder A; Agatheeswaran S; Biswas G; Biswas S; Pattnayak NC; Chakraborty S
    Leuk Lymphoma; 2017 Aug; 58(8):1941-1947. PubMed ID: 27967290
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Persistent polyclonal binucleated B-cell lymphocytosis and mecom gene amplification.
    Cornet E; Mossafa H; Courel K; Lesesve JF; Troussard X
    BMC Res Notes; 2016 Mar; 9():138. PubMed ID: 26935937
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.